SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-031231
Filing Date
2022-11-10
Accepted
2022-11-10 08:00:46
Documents
83
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1242041
2 ex1-1.htm EX-1.1 272900
3 ex31-1.htm EX-31.1 17927
4 ex31-2.htm EX-31.2 18137
5 ex32-1.htm EX-32.1 6372
6 ex32-2.htm EX-32.2 6388
  Complete submission text file 0001493152-22-031231.txt   6269396

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE vbiv-20220930.xsd EX-101.SCH 54021
8 XBRL CALCULATION FILE vbiv-20220930_cal.xml EX-101.CAL 71343
9 XBRL DEFINITION FILE vbiv-20220930_def.xml EX-101.DEF 193433
10 XBRL LABEL FILE vbiv-20220930_lab.xml EX-101.LAB 397269
11 XBRL PRESENTATION FILE vbiv-20220930_pre.xml EX-101.PRE 307786
77 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 847066
Mailing Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142
Business Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37769 | Film No.: 221375028
SIC: 2834 Pharmaceutical Preparations